Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination.

Ishizuka, K; Katayama, K; Kaji, Y; Tawara, J; Ohira, Y

Ishizuka, K; Katayama, K; Kaji, Y; Tawara, J; Ohira, Y.

Afiliación

Ishizuka K; Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.
Katayama K; Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.
Kaji Y; Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.
Tawara J; Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.
Ohira Y; Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.

QJM ; 114(10): 745-746, 2021 12 20.

Article en En | MEDLINE | ID: mdl-34546346

Asunto(s)

Angioedema; COVID-19; Eosinofilia; Angioedema/inducido químicamente; Vacuna BNT162; Vacunas contra la COVID-19; Humanos; ARN Mensajero; SARS-CoV-2; Vacunación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Eosinofilia / COVID-19 / Angioedema Idioma: En Revista: QJM Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google